Dynatronics (DYNT) Competitors $0.08 +0.00 (+0.50%) As of 08/1/2025 02:20 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock DYNT vs. NDRA, CHEK, BLAC, HSCS, XAGE, VERO, AMIX, TIVC, GCTK, and AEMDShould you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include ENDRA Life Sciences (NDRA), Check-Cap (CHEK), Bellevue Life Sciences Acquisition (BLAC), HeartSciences (HSCS), Longevity Health (XAGE), Venus Concept (VERO), Autonomix Medical (AMIX), Tivic Health Systems (TIVC), GlucoTrack (GCTK), and Aethlon Medical (AEMD). These companies are all part of the "medical equipment" industry. Dynatronics vs. Its Competitors ENDRA Life Sciences Check-Cap Bellevue Life Sciences Acquisition HeartSciences Longevity Health Venus Concept Autonomix Medical Tivic Health Systems GlucoTrack Aethlon Medical ENDRA Life Sciences (NASDAQ:NDRA) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Which has better earnings & valuation, NDRA or DYNT? Dynatronics has higher revenue and earnings than ENDRA Life Sciences. Dynatronics is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENDRA Life SciencesN/AN/A-$11.51M-$172.04-0.03Dynatronics$33.60M0.03-$2.70M-$0.78-0.10 Is NDRA or DYNT more profitable? ENDRA Life Sciences has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ENDRA Life SciencesN/A -140.96% -106.14% Dynatronics -8.35%-41.81%-9.56% Do analysts rate NDRA or DYNT? ENDRA Life Sciences presently has a consensus target price of $50.00, indicating a potential upside of 933.06%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe ENDRA Life Sciences is more favorable than Dynatronics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in NDRA or DYNT? 1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 0.0% of ENDRA Life Sciences shares are owned by insiders. Comparatively, 8.0% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, NDRA or DYNT? ENDRA Life Sciences has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Does the media prefer NDRA or DYNT? In the previous week, ENDRA Life Sciences had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for ENDRA Life Sciences and 0 mentions for Dynatronics. Dynatronics' average media sentiment score of 0.00 beat ENDRA Life Sciences' score of -1.00 indicating that Dynatronics is being referred to more favorably in the news media. Company Overall Sentiment ENDRA Life Sciences Negative Dynatronics Neutral SummaryDynatronics beats ENDRA Life Sciences on 9 of the 15 factors compared between the two stocks. Get Dynatronics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYNT vs. The Competition Export to ExcelMetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.06M$65.47M$5.49B$9.54BDividend YieldN/AN/A4.73%4.09%P/E Ratio-0.106.2128.8323.83Price / Sales0.03109.49372.0766.02Price / CashN/A18.4135.4557.96Price / Book0.147.368.275.54Net Income-$2.70M-$25.86M$3.25B$259.28M7 Day PerformanceN/A-7.07%-3.73%-4.68%1 Month PerformanceN/A2.26%4.29%4.36%1 Year PerformanceN/A46.72%25.87%17.88% Dynatronics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYNTDynatronicsN/A$0.08+0.5%N/A-63.6%$1.06M$33.60M-0.10200Gap UpNDRAENDRA Life Sciences1.4453 of 5 stars$5.91-7.0%$50.00+746.7%-99.9%$4.43MN/A-0.0320Negative NewsShort Interest ↑Gap DownCHEKCheck-CapN/A$0.73-2.3%N/A-66.1%$4.27MN/A-0.2480Gap DownBLACBellevue Life Sciences AcquisitionN/A$0.94-3.7%N/A-93.6%$3.81MN/A0.00N/AHigh Trading VolumeHSCSHeartSciences2.287 of 5 stars$3.53-0.3%$13.00+268.4%-21.6%$3.81MN/A-0.3810News CoverageUpcoming EarningsXAGELongevity HealthN/A$3.72-4.9%N/AN/A$3.72M$50K0.0014News CoverageVEROVenus Concept1.3157 of 5 stars$2.51-1.4%N/A-66.2%$3.57M$61.00M-0.03410Positive NewsAMIXAutonomix Medical3.1601 of 5 stars$1.24-5.7%$16.50+1,236.0%-93.3%$3.43MN/A-0.171Gap DownHigh Trading VolumeTIVCTivic Health Systems0.6315 of 5 stars$3.65-8.1%N/A-71.4%$3.21M$780K0.0010Positive NewsGCTKGlucoTrack0.2626 of 5 stars$6.57-4.1%N/A-99.6%$3.17MN/A-0.125News CoveragePositive NewsAEMDAethlon Medical1.3852 of 5 stars$1.21-5.5%$56.00+4,528.1%-56.3%$3.14M$570K-0.1010Positive NewsGap Down Related Companies and Tools Related Companies ENDRA Life Sciences Competitors Check-Cap Competitors Bellevue Life Sciences Acquisition Competitors HeartSciences Competitors Longevity Health Competitors Venus Concept Competitors Autonomix Medical Competitors Tivic Health Systems Competitors GlucoTrack Competitors Aethlon Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DYNT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynatronics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynatronics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.